CERo Therapeutics Holdings, Inc. - Common Stock, $0.0001 par value per share (CERO)

Historical Holders from Q4 2021 to Q2 2025

Symbol
CERO on Nasdaq
Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
5,169,697
All holders as of 30 Jun 2025
Q2 2025
Total 13F shares, excl. options
400
Holdings value
$24
% of all portfolios
0%
Number of holders
1
Number of buys
1
Average buys %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of CERo Therapeutics Holdings, Inc. - Common Stock, $0.0001 par value per share (CERO)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ATWOOD BRIAN G 9.9% +45.7% $20,472 +$12,376 511,800 +153% Brian G. Atwood 31 Mar 2025
YK Bioventures Opportunities GP I, LLC 0% $680 17,002 YK Bioventures Opportunities GP I, LLC 13 Dec 2024

Institutional Holders of CERo Therapeutics Holdings, Inc. - Common Stock, $0.0001 par value per share (CERO)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q2 400 $24 +$24 $0.0600 1
2025 Q1 0 $0 -$956,030 0
2024 Q4 13,323,470 $956,030 +$580,962 $0.0600 19
2024 Q3 3,442,262 $320,034 +$160,796 $0.0933 17
2024 Q2 1,867,063 $557,115 +$77,506 $0.2990 14
2024 Q1 1,515,173 $4,651,346 -$2,752,548 $3.07 8
2023 Q4 679,166 $7,488,174 +$53,470 $11.00 8
2023 Q3 675,140 $7,332,178 -$3,254,170 $10.86 9
2023 Q2 976,580 $10,615,889 -$2,060,042 $10.90 12
2023 Q1 1,174,274 $12,543,454 -$89,026,453 $10.68 15
2022 Q4 9,845,770 $101,108,715 -$50,175,043 $10.27 45
2022 Q3 15,151,664 $152,959,000 +$5,823,455 $10.09 65
2022 Q2 14,419,635 $144,538,000 +$5,286,548 $10.02 54
2022 Q1 13,715,709 $137,190,000 +$31,998,515 $10.00 45
2021 Q4 10,510,900 $104,167,000 +$90,475,000 $9.91 36